JAK Inhibition: Are the Promises Fulfilled?

preview_player
Показать описание
Join Professors Lai-Shan Tam, Ernest Choy, Peter Nash, and Hideto Kameda for a discussion and presentation on JAK inhibitor therapy. Presented at APLAR 2022.
  1. The Immune-Mediated Inflammatory Disease Forum
Рекомендации по теме
JAK Inhibition: Are 0:53:32

JAK Inhibition: Are the Promises Fulfilled?

Adverse Events Seen 0:04:01

Adverse Events Seen with JAK Inhibition in MPN

Targeting the PI3K 0:01:34

Targeting the PI3K pathway in patients who fail JAK inhibitor therapy

Targeted therapies beyond 0:01:23

Targeted therapies beyond JAK inhibitors

Considerations for JAK 0:04:34

Considerations for JAK Inhibition for the Treatment of PV

Discussing Rheumatology: JAK 0:07:59

Discussing Rheumatology: JAK Inhibitor Monotherapy in RA

Forum LIVE: The 0:58:38

Forum LIVE: The role of JAK inhibitors in the treatment algorithm

JAK Inhibitors in 0:01:48

JAK Inhibitors in Steroid-Refractory GVHD

Nancy Gupta, MD 0:06:31

Nancy Gupta, MD | The Origin of Black Box Warnings with JAK Inhibitors

JAK Inhibitors and 0:03:56

JAK Inhibitors and COVID-19

The promise of 0:01:44

The promise of parsaclisib in patients with MF who have a suboptimal response to JAKi therapy

The role of 0:15:32

The role of JAK inhibitors in your clinical practice

Mechanism of JAK 0:05:21

Mechanism of JAK Inhibitors and a Review of Ruxolitinib

Dr. Masarova on 0:01:01

Dr. Masarova on the Safety of JAK Inhibitor/Targeted Therapy Combos in Myelofibrosis

JAK-Inhibition in Immune-Mediated 0:43:42

JAK-Inhibition in Immune-Mediated Diseases (IMiDs)

JAK Kinase Inhibitors 0:02:09

JAK Kinase Inhibitors

JAK inhibitor treatment 0:06:20

JAK inhibitor treatment shows benefit for patients with interferonopathies

A user's guide 0:22:51

A user's guide to JAK inhibition for IBD

Analysis of JAK 0:02:47

Analysis of JAK inhibitors and risk of secondary B-cell lymphomas in MPN patients

Managing cytopenias following 0:01:22

Managing cytopenias following JAK inhibitor treatment & achieving true disease modification in M...

The Expanding Role 0:36:51

The Expanding Role of JAK Inhibitors Across IMIDs

Discussing Rheumatology: JAK 0:20:17

Discussing Rheumatology: JAK Inhibitors

Novel therapies for 0:02:04

Novel therapies for myelofibrosis patients who have failed JAK inhibitors

Approved & emerging 0:02:09

Approved & emerging JAK inhibitors for patients with high-risk MF who are transplant-ineligible

visit shbcf.ru